$1.01T
Total marketcap
$84.36B
Total volume
37.88%
BTC dominance

Pfizer PFE Stock

43.76 USD {{ price }} -0.905801% {{change_pct}}%
Exchange
NYSE
Market Cap
245.6B USD
LOW - HIGH [24H]
43.73 - 44.61 USD
VOLUME [24H]
21.64M USD
{{ volume }}
P/E Ratio
8.51
Earnings per share
5.14 USD

Pfizer Price Chart

Pfizer PFE Financial and Trading Overview

Pfizer stock price 43.76 USD
Previous Close 44.16 USD
Open 44.17 USD
Bid 0 USD x 3200
Ask 0 USD x 2200
Day's Range 43.73 - 44.61 USD
52 Week Range 40.94 - 61.71 USD
Volume 21.64M USD
Avg. Volume 17.66M USD
Market Cap 245.6B USD
Beta (5Y Monthly) 0.654015
PE Ratio (TTM) 8.513618
EPS (TTM) 5.14 USD
Forward Dividend & Yield 1.6 (3.66%)
Ex-Dividend Date November 3, 2022
1y Target Est 56.81 USD

PFE Valuation Measures

Enterprise Value 253.04B USD
Trailing P/E 8.513618
Forward P/E 0.7322624
PEG Ratio (5 yr expected) 1.26
Price/Sales (ttm) 2.4250448
Price/Book (mrq) 2.8065674
Enterprise Value/Revenue 2.498
Enterprise Value/EBITDA 5.814

Trading Information

Pfizer Stock Price History

Beta (5Y Monthly) 0.654015
52-Week Change 3.15%
S&P500 52-Week Change -16.62%
52 Week High 61.71 USD
52 Week Low 40.94 USD
50-Day Moving Average 47.65 USD
200-Day Moving Average 50.98 USD

PFE Share Statistics

Avg. Volume (3 month) 17.66M USD
Avg. Daily Volume (10-Days) 17.98M USD
Shares Outstanding 5.61B
Float 5.61B
Short Ratio 3.92
% Held by Insiders 0.045%
% Held by Institutions 70.09%
Shares Short 63.89M
Short % of Float 1.14%
Short % of Shares Outstanding 1.14%

Dividends & Splits

Trailing Annual Dividend Rate 1.58
Trailing Annual Dividend Yield 3.57%
5 Year Average Dividend Yield 360.00%
Payout Ratio 0.3074
Last Split Factor 1054:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) July 3, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 28.93%
Operating Margin (ttm) 38.05%
Gross Margin 62.75%
EBITDA Margin 42.97%

Management Effectiveness

Return on Assets (ttm) 13.18%
Return on Equity (ttm) 37.39%

Income Statement

Revenue (ttm) 101.28B USD
Revenue Per Share (ttm) 18.06 USD
Quarterly Revenue Growth (yoy) 46.80%
Gross Profit (ttm) 50.63B USD
EBITDA 43.52B USD
Net Income Avi to Common (ttm) 29.48B USD
Diluted EPS (ttm) 5.14
Quarterly Earnings Growth (yoy) 78.10%

Balance Sheet

Total Cash (mrq) 33.31B USD
Total Cash Per Share (mrq) 5.94 USD
Total Debt (mrq) 40.49B USD
Total Debt/Equity (mrq) 46.29 USD
Current Ratio (mrq) 1.423
Book Value Per Share (mrq) 15.592

Cash Flow Statement

Operating Cash Flow (ttm) 31.45B USD
Levered Free Cash Flow (ttm) 29.06B USD

Profile of Pfizer

Country United States
State NY
City New York
Address 235 East 42nd Street
ZIP 10017
Phone 212 733 2323
Website https://www.pfizer.com
Industry Drug Manufacturers—General
Sector(s) Healthcare
Full Time Employees 79000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Q&A For Pfizer Stock

What is a current PFE stock price?

Pfizer PFE stock price today per share is 43.76 USD.

How to purchase Pfizer stock?

You can buy PFE shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pfizer?

The stock symbol or ticker of Pfizer is PFE.

Which industry does the Pfizer company belong to?

The Pfizer industry is Drug Manufacturers—General.

How many shares does Pfizer have in circulation?

The max supply of Pfizer shares is 5.61B.

What is Pfizer Price to Earnings Ratio (PE Ratio)?

Pfizer PE Ratio is 8.51361800 now.

What was Pfizer earnings per share over the trailing 12 months (TTM)?

Pfizer EPS is 5.14 USD over the trailing 12 months.

Which sector does the Pfizer company belong to?

The Pfizer sector is Healthcare.